Twin City Private Wealth’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.68M Buy
9,159
+4,392
+92% +$1.44M 2.03% 13
2025
Q4
$1.67M Buy
4,767
+289
+6% +$97.7K 1.26% 29
2025
Q3
$1.45M Sell
4,478
-428
-9% -$133K 1.13% 34
2025
Q2
$1.91M Buy
4,906
+928
+23% +$373K 1.56% 23
2025
Q1
$1.73M Sell
3,978
-163
-4% -$65.4K 1.52% 23
2024
Q4
$1.53M Buy
4,141
+609
+17% +$255K 1.35% 29
2024
Q3
$1.84M Buy
3,532
+163
+5% +$87.1K 1.59% 24
2024
Q2
$1.83M Buy
3,369
+272
+9% +$144K 1.72% 20
2024
Q1
$1.61M Buy
+3,097
New +$1.54M 1.58% 26

Other funds holding ELV

Twin City Private Wealth's ELV Position: Q1 2026 in Review

Twin City Private Wealth increased its Elevance Health (ELV) stake by 92% in Q1 2026, buying an estimated $1.44M and bringing the position to 9,159 shares worth $2.68M. The position accounts for 2.03% of the portfolio, ranked #13.

Twin City Private Wealth first reported a position in ELV in Q1 2024 and has held it in 9 quarters since. 1,464 funds tracked by Wall St. Rank hold ELV as of Q1 2026.

  • Twin City Private Wealth held 9,159 shares of Elevance Health worth $2.68M as of Q1 2026.
  • Twin City Private Wealth bought 4,392 Elevance Health shares in Q1 2026, an estimated $1.44M.
  • Elevance Health made up 2.03% of Twin City Private Wealth's portfolio in Q1 2026, its #13 holding.
  • Twin City Private Wealth first reported a position in Elevance Health in Q1 2024 and has held it in 9 quarters since.
  • 1,464 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.

Based on Twin City Private Wealth's 13F filing for Q1 2026, filed 24 Apr 2026.